No new info from what I heard on the podcast. Emphasis is mine.
Nothing about manufacturing or Lonza.
Things SI said that stood out
- ARDS trial total patient recruitment of about 300 expected to take in 3-4 months
- In the meantime we will have early interim analyses released that hopefully will show that the sort of efficacy in the pilot study will be replicated
- Number of trial readouts coming this year
- First product about to be launched for gvhd
- Hope the covid product will be the second
MSB - Most exciting 6 months, page-366
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.005(0.32%) |
Mkt cap ! $1.798B | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.52 | $6.446M | 4.092M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 62215 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 14678 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |